AAG
SLS icon

Armstrong Advisory Group’s SELLAS Life Sciences SLS Stock Holding History

Armstrong Advisory Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61K Buy
+380
New +$2.62K ﹤0.01% 779

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
FD
Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Armstrong Advisory Group's SLS Position: Q2 2026 in Review

Armstrong Advisory Group opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 380 shares worth $5.61K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings.

21 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Armstrong Advisory Group held 380 shares of SELLAS Life Sciences worth $5.61K as of Q2 2026.
  • SELLAS Life Sciences was a new Armstrong Advisory Group position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #779 holding.
  • 21 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.